DIALYSIS · CCN 452672

DaVita Weslaco Renal Center

WESLACO, TX 78596

DialysisProfitDaVita
$3.5M
TOTAL REVENUE
26.8%
OPERATING MARGIN
2 / 5
STAR RATING
11
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$3.5M
Total costs
$2.6M
Operating income (rev − costs)
$936K
Operating margin
26.8%
Total charges
$3.6M
Total treatments
8,139
Dialysis stations
20

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

11 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.8213—
Fistula Rate
DFC_FISTULA_RATE
42.662—
Five Star Rating
DFC_FIVE_STAR
2——
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
4——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
12956—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
2062—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
23.4258—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
11.750—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
32.350—
Standardized ED Visits Ratio
DFC_SEDR
1.3713—